[HTML][HTML] Efficacy and safety of direct oral anticoagulants approved for cardiovascular indications: Systematic review and meta-analysis
RCP Makam, DC Hoaglin, DD McManus, V Wang… - PloS one, 2018 - journals.plos.org
Background Direct oral anticoagulants (DOACs) have emerged as promising alternatives to
vitamin K antagonists (VKAs) for patients with non-valvular atrial fibrillation (NVAF) or …
vitamin K antagonists (VKAs) for patients with non-valvular atrial fibrillation (NVAF) or …
Efficacy and safety of direct oral anticoagulants approved for cardiovascular indications: Systematic review and meta-analysis.
RCP Makam, DC Hoaglin, DD McManus, V Wang… - Plos one, 2018 - europepmc.org
Background Direct oral anticoagulants (DOACs) have emerged as promising alternatives to
vitamin K antagonists (VKAs) for patients with non-valvular atrial fibrillation (NVAF) or …
vitamin K antagonists (VKAs) for patients with non-valvular atrial fibrillation (NVAF) or …
[PDF][PDF] Efficacy and safety of direct oral anticoagulants approved for cardiovascular indications: Systematic review and meta-analysis
RCP Makam, DC Hoaglin, DD McManus… - PLoS …, 2018 - pdfs.semanticscholar.org
Background Direct oral anticoagulants (DOACs) have emerged as promising alternatives to
vitamin K antagonists (VKAs) for patients with non-valvular atrial fibrillation (NVAF) or …
vitamin K antagonists (VKAs) for patients with non-valvular atrial fibrillation (NVAF) or …
Efficacy and safety of direct oral anticoagulants approved for cardiovascular indications: Systematic review and meta-analysis
RCP Makam, DC Hoaglin, DD McManus… - PloS …, 2018 - pubmed.ncbi.nlm.nih.gov
Background Direct oral anticoagulants (DOACs) have emerged as promising alternatives to
vitamin K antagonists (VKAs) for patients with non-valvular atrial fibrillation (NVAF) or …
vitamin K antagonists (VKAs) for patients with non-valvular atrial fibrillation (NVAF) or …
Efficacy and safety of direct oral anticoagulants approved for cardiovascular indications: Systematic review and meta-analysis.
RCP Makam, DC Hoaglin, DD McManus… - PLoS …, 2018 - search.ebscohost.com
Abstract Background: Direct oral anticoagulants (DOACs) have emerged as promising
alternatives to vitamin K antagonists (VKAs) for patients with non-valvular atrial fibrillation …
alternatives to vitamin K antagonists (VKAs) for patients with non-valvular atrial fibrillation …
[PDF][PDF] Efficacy and safety of direct oral anticoagulants approved for cardiovascular indications: Systematic review and meta-analysis
RCP Makam, DC Hoaglin, DD McManus, V Wang… - PLoS ONE, 2018 - core.ac.uk
Background Direct oral anticoagulants (DOACs) have emerged as promising alternatives to
vitamin K antagonists (VKAs) for patients with non-valvular atrial fibrillation (NVAF) or …
vitamin K antagonists (VKAs) for patients with non-valvular atrial fibrillation (NVAF) or …
[HTML][HTML] Efficacy and safety of direct oral anticoagulants approved for cardiovascular indications: Systematic review and meta-analysis
RCP Makam, DC Hoaglin, DD McManus, V Wang… - PLoS ONE, 2018 - ncbi.nlm.nih.gov
Background Direct oral anticoagulants (DOACs) have emerged as promising alternatives to
vitamin K antagonists (VKAs) for patients with non-valvular atrial fibrillation (NVAF) or …
vitamin K antagonists (VKAs) for patients with non-valvular atrial fibrillation (NVAF) or …
Efficacy and safety of direct oral anticoagulants approved for cardiovascular indications: Systematic review and meta-analysis
RCP Makam, DC Hoaglin, DD McManus… - PLOS …, 2018 - econpapers.repec.org
Background: Direct oral anticoagulants (DOACs) have emerged as promising alternatives to
vitamin K antagonists (VKAs) for patients with non-valvular atrial fibrillation (NVAF) or …
vitamin K antagonists (VKAs) for patients with non-valvular atrial fibrillation (NVAF) or …
[引用][C] Efficacy and safety of direct oral anticoagulants approved for cardiovascular indications: Systematic review and meta-analysis
RCP Makam, DC Hoaglin, DD McManus… - PLoS …, 2018 - ui.adsabs.harvard.edu
Efficacy and safety of direct oral anticoagulants approved for cardiovascular indications:
Systematic review and meta-analysis - NASA/ADS Now on home page ads icon ads Enable full …
Systematic review and meta-analysis - NASA/ADS Now on home page ads icon ads Enable full …
Efficacy and safety of direct oral anticoagulants approved for cardiovascular indications: Systematic review and meta-analysis
RCP Makam, DC Hoaglin, DD McManus, V Wang… - PLoS ONE, 2018 - go.gale.com
Background Direct oral anticoagulants (DOACs) have emerged as promising alternatives to
vitamin K antagonists (VKAs) for patients with non-valvular atrial fibrillation (NVAF) or …
vitamin K antagonists (VKAs) for patients with non-valvular atrial fibrillation (NVAF) or …